Teva's Generic Viagra Set to hit market in 2017

Generic Viagra will hit the U.S. market more than two years earlier than had been anticipated under a settlement reached by Teva Pharmaceutical Industries Ltd. and the maker of the impotence drug, Pfizer Inc.

Teva can enter the market on Dec. 11, 2017, and will pay patent royalties through the expiration of the Viagra patent in April 2020, New York-based Pfizer said in a statement. Other settlement terms have not been disclosed. Read the full story.

More News:

All news »

What are your comments?

Join the discussion today. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments